Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Savara Inc. (SVRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.2600+0.0200 (+1.61%)
At close: 4:00PM EDT
1.2800 +0.02 (+1.59%)
After hours: 06:39PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.2400
Open1.2400
Bid1.2400 x 800
Ask1.2700 x 2900
Day's Range1.2300 - 1.2800
52 Week Range0.9950 - 3.5800
Volume289,835
Avg. Volume384,755
Market Cap143.19M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-0.6920
Earnings DateAug 04, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.00
  • Business Wire

    Savara to Present at the Inaugural Piper Sandler Lung Day

    AUSTIN, Texas, October 07, 2021--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a Fireside Chat at the Inaugural Piper Sandler Lung Day on Friday, October 15, 2021 at 10:30 am ET / 7:30 am PT.

  • Benzinga

    3 Penny Stocks Insiders Are Buying

    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Savara The Trade: Savara Inc. (NASDAQ: SVRA) Director David Ramsay acquired a total of 137052 shares at an average price o

  • Business Wire

    Savara to Participate in Two Upcoming Investor Healthcare Conferences

    AUSTIN, Texas, September 07, 2021--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the following healthcare conferences:

Advertisement
Advertisement